Navigation Links
Survey: Hiding risks can hurt public support for nanotechnology
Date:5/4/2010

A new national survey on public attitudes toward medical applications and physical enhancements that rely on nanotechnology shows that support for the technology increases when the public is informed of the technology's risks as well as its benefits at least among those people who have heard of nanotechnology. The survey, which was conducted by researchers at North Carolina State University and Arizona State University (ASU), also found that discussing risks decreased support among those people who had never previously heard of nanotechnology but not by much.

"The survey suggests that researchers, industries and policymakers should not be afraid to display the risks as well as the benefits of nanotechnology," says Dr. Michael Cobb, an associate professor of political science at NC State who conducted the survey. "We found that when people know something about nanotechnologies for human enhancement, they are more supportive of it when they are presented with balanced information about its risks and benefits."

The survey was conducted by Cobb in collaboration with Drs. Clark Miller and Sean Hays of ASU, and was funded by the Center for Nanotechnology in Society at ASU.

However, talking about risks did not boost support among all segments of the population. Those who had never heard of nanotechnology prior to the survey were slightly less supportive when told of its potential risks.

In addition to asking participants how much they supported the use of nanotechnology for human enhancements, they were also asked how beneficial and risky they thought these technologies would be, whether they were worried about not getting access to them, and who should pay for them health insurance companies or individuals paying out-of-pocket. The potential enhancements addressed in the survey run the gamut from advanced cancer treatments to bionic limbs designed to impart greater physical strength.

One segment of participants was shown an image of an unrealistic illustration meant to represent a nanoscale medical device. A second segment was shown the image and given a "therapeutic" framing statement that described the technology as being able to restore an ill person to full health. A third segment was given the image, along with an "enhancement" framing statement that described the technology as being able to make humans faster, stronger and smarter. Two additional segments were given the image, the framing statements and information about potential health risks. And a final segment of participants was not given the image, a framing statement or risk information.

The survey found that describing the technology as therapeutic resulted in much greater public support for the technology, as well as a greater perception of its potential benefits. The therapeutic frame also resulted in increased support for health insurance coverage of nanotech treatments once they become available, and increased concerns that people wouldn't be able to afford such treatments without insurance coverage.

"These findings suggest that researchers, policymakers and industries would be well advised to focus their research efforts on developing therapeutic technologies, rather than enhancements, because that is the area with the greatest public support," Cobb says.

The use of the nanotech image did not have a significant overall impact on participants' support, but did alarm people who were not previously familiar with nanotechnology making them less likely to support it.


'/>"/>

Contact: Matt Shipman
matt_shipman@ncsu.edu
919-515-6386
North Carolina State University
Source:Eurekalert

Related medicine news :

1. Survey: Toyota owners maintain high overall satisfaction despite recalls
2. Survey: Over 40 Percent of Nurses to Alter Career Path
3. Depression Survey: Implications for Diverse Communities
4. Depression Survey: Implications for Diverse Communities
5. Thomson Reuters Survey: Most Americans Support Public Option in Healthcare Reform Legislation but Are Skeptical Healthcare Will Improve in 2010
6. Smoking While Pregnant May Raise Psychiatric Risks in Kids
7. Radiation Risks Nearly Double for Younger CT Scan Patients
8. Kids Raised by Relatives Face Increased Health Risks
9. Genome Scan Gives Man Insight Into Future Health Risks
10. Breast Cancer Risks Not Same for Hispanic Women
11. Weight-Loss Surgery May Ease Childbirth Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of ... award to iHire in recognition of their exemplary accomplishments in worksite health promotion. , ... Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at www.diabetesscholars.org by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
Breaking Medicine Technology: